Appendiceal Mucinous Neoplasms, Desmoplastic Small Round Cell Tumor, Diffuse Peritoneal Leiomyomatosis, Peritoneal Mesothelioma, Primary Peritoneal Serous Carcinoma, Psammocarcinoma, Pseudomyxoma Peritonei, Rare Peritoneal Surface Malignancies
Conditions
Keywords
Rare peritoneal surface malignancies, pseudomyxoma peritonei, peritoneal mesothelioma, desmoplastic small round cell tumor, psammocarcinoma, primary peritoneal serous carcinoma, diffuse peritoneal leiomyomatosis, appendiceal mucinous neoplasms, registry, population-based database
Brief summary
Despite advances in the management of and changes in clinical practice, little is known about the epidemiology, patterns of care and outcomes of rare peritoneal surface malignancies patients in France. In order to better understand the characteristics of rare peritoneal surface malignancies and to evaluate treatment strategies, the RENAPE registry aims at the collection of data from patients presenting with a rare peritoneal surface malignancy in France. Data will be entered prospectively in a specifically designed and secured web database. All RENAPE's centres and physicians are invited to register patients with a rare peritoneal surface malignancy diagnosis and to participate to the registry. Data will be evaluated within regular time frames, focusing on types of rare peritoneal surface malignancies, treatment modalities and patient outcomes (e.g. survival, recurrence), thereby contributing to the better understanding of these rare cancers.
Interventions
Data collection
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients are eligible if they have a histologically proven rare peritoneal surface malignancy.
Exclusion criteria
* Histological diagnostic of peritoneal surface malignancy not confirmed * Expected clinical follow up data not available
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Incidence of rare peritoneal surface malignancies | year 5 | Collect detailed clinical and histological diagnosis for estimating annual incidence rate |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Impact of specific treatment strategies | year 5 | Collect detailed therapeutic strategies (surgical procedure, chemotherapy, etc.) on patients with rare peritoneal surface malignancies |
Countries
France